Catapult Ventures

Catapult Ventures, an independent asset management firm founded in 1999 and headquartered in Leicester, specializes in early-stage investments across various sectors, including technology, life sciences, healthcare, medical devices, luxury consumer brands, manufacturing, and software. The firm is staffed by a highly experienced team of venture capital investors with a broad background that encompasses all stages of company development, from start-ups and pre-revenue intellectual property developers to established firms generating significant revenue. This expertise is complemented by an administration team, where each member possesses over a decade of experience in the venture capital field. Through its dedicated approach, Catapult Ventures aims to support innovative companies in the UK, fostering growth and development in key industries.

Duncan Cameron

CFO

Rob Carroll

Director

Vijay Curthan

Investment Director

Christopher Spencer

Venture Partner, Catapult's GM&C Life Sciences Fund

Laurence Vaughan

Chairman

Nick Wright

CEO

98 past transactions

Strella

Series A in 2022
Strella Biotechnology, Inc. designs and manufactures sensors based device that maximizes the freshness of fresh produce throughout the supply chain. The company provides an ethylene-detection device that determines ripeness by calculating the ethylene gas produced by fruit and maximizes freshness and reduces spoilage of fruit. Strella Biotechnology, Inc. was founded in 2018 and is based in Philadelphia, Pennsylvania.

Urban Machine

Pre Seed Round in 2021
Operator of a wood reclamation company intended to remove staples and nails from reclaimed wood to turn it into premium lumber products. The company reclaims used wood from demolition sites, and waste pieces from new construction, it helps build machines leveraging the latest robotics and (Artificial Intelligence) AI for salvaging lumber waste so it can be used to build again at a price competitive to virgin lumber, enabling firms to eliminate waste and reduce the environmental impact of the construction industry.

Viscgo

Venture Round in 2021
Viscgo Limited designs, develops, and delivers devices and technology to improve the management of dysphagia for patients, caretakers, and clinicians. The company’s product includes drink thickness testers. The company was founded in 2015 and is based in Warrington, United Kingdom.

Maxwellia

Venture Round in 2021
Maxwellia Ltd is a UK-based company that specializes in converting prescription medications into over-the-counter (OTC) products, enabling consumers to manage their health without the need for a doctor's prescription. Established in 2013, Maxwellia employs a comprehensive approach to this "switching" process through its various services. These include SwitchScreen, which identifies potential drug candidates; SwitchUp, which outlines the design and risk factors involved in the switch; and SwitchAbility, which supports the entire process from concept to market launch. By focusing on established prescription drugs, the company aims to create new consumer brands that enhance self-care options available in pharmacies and online. Maxwellia's innovative methods help navigate the complexities of drug switching, providing a pathway for the development and commercialization of self-care products in diverse therapeutic categories.

Camect

Pre Seed Round in 2020
Camect, Inc. specializes in developing and selling advanced video surveillance technologies designed for both residential and commercial use. The company offers Camect Home, a smart security camera that features 24/7 local recording and AI-powered alert detection, as well as Camect Go, a web app subscription service that allows users to access their camera feeds remotely. This service includes features such as email alerts, app notifications, cloud storage for motion videos, and the ability to share content with others. Camect's system is compatible with a wide range of camera brands, providing users with enhanced alert capabilities and a user-friendly interface, all while ensuring local data privacy. Established in 2017 and based in Mountain View, California, Camect aims to provide a comprehensive and cost-effective security solution.

Strella

Seed Round in 2020
Strella Biotechnology, Inc. designs and manufactures sensors based device that maximizes the freshness of fresh produce throughout the supply chain. The company provides an ethylene-detection device that determines ripeness by calculating the ethylene gas produced by fruit and maximizes freshness and reduces spoilage of fruit. Strella Biotechnology, Inc. was founded in 2018 and is based in Philadelphia, Pennsylvania.

Left Hand Robotics

Series A in 2019
Left Hand Robotics, Inc. specializes in developing commercial-grade robots designed for outdoor labor-intensive tasks. The company's flagship product, the RT-1000 ROBOT, is a fully autonomous workbot capable of mowing grass and clearing snow. It can be equipped with various attachments, including a MOWER DECK for cutting large grassy areas, a SNOW BROOM for snow removal, and a DEICER BOX for treating icy sidewalks and bike paths. The robots are controlled and monitored via an online management dashboard, utilizing GPS for navigation along pre-programmed paths. Founded in 2016 and based in Longmont, Colorado, Left Hand Robotics aims to enhance efficiency and reduce labor costs in outdoor maintenance tasks.

advanced.farm

Series A in 2019
Advanced Farm Technologies Inc. is a robotics company based in Davis, California, specializing in advanced farming solutions. Founded in 2017, the company focuses on strawberry harvesting services in the Oxnard, Santa Maria, and Watsonville regions. Its robotic harvesting systems are designed to gently handle strawberries, minimizing bruising and damage to the fruit. By providing innovative harvesting technology, Advanced Farm Technologies aims to modernize agricultural practices and enhance efficiency for farmers.

Rinicare

Venture Round in 2018
Rinicare Ltd. is a healthcare technology company based in Macclesfield, United Kingdom, that specializes in designing and manufacturing innovative monitoring devices. The company produces the PRIME device, which offers vital sign monitoring and data analysis through wireless sensors, allowing clinicians to remotely access, transmit, and store patient information. Additionally, Rinicare develops the PRIME IoT, which facilitates data transmission to compatible devices via healthcare application software. The company also offers a falls detection and prevention system called SAFE, utilizing thermal imaging sensors and intelligent algorithms to monitor patients’ risk of falling in real-time. Alongside these devices, Rinicare creates application software that tracks comprehensive patient data, enhancing clinical risk prediction and improving patient care outcomes. Established in 2002, Rinicare aims to integrate its solutions seamlessly into existing healthcare infrastructures to support timely and informed decision-making by clinicians.

Renephra

Seed Round in 2018
Renephra Ltd is a medical device company developing a groundbreaking Transdermal Fluid Removal (TFR) technology for minimally invasive fluid removal. We are targeting the significant problems of fluid overload and chronic oedema / lymphoedema in vascular, oncology and other disease areas. This is a substantial patient group with unmet clinical needs and is an estimated £1billion market worldwide. Having achieved proof of concept in humans, Renephra is raising £400k to conduct device development study and design feasability.

Acea Health

Seed Round in 2018
Acea Health is a digital healthcare company developing an application called Flynotes - a new digital consent platform. Flynotes analyses a number of factors, including the patient’s background, to deliver personalised risks and benefits. Flynotes aims to be the go-to solution for consent in healthcare. .

metaLinear

Seed Round in 2017
metaLinear Ltd. is a biotechnology company based in Alderley Edge, United Kingdom, founded in 2016. The company specializes in engineering microbial proteomes to identify and validate novel drug targets for challenging bacterial infections. By leveraging its proprietary proteome engineering platform, metaLinear develops large libraries of randomized proteins expressed in target bacteria to screen for new antibiotic targets. This innovative approach aims to streamline the drug discovery process by mitigating risks associated with target identification, ultimately enhancing the efficiency of antibiotic development. Through its advanced methodologies, metaLinear seeks to address significant challenges in treating difficult-to-treat bacterial infections.

MicroBioSensor

Venture Round in 2017
MicroBioSensor Ltd. is a medical device company based in Manchester, United Kingdom, focused on developing disposable point-of-care devices for the early detection of microbial infections and antibiotic resistance. Founded in 2012, the company specializes in creating easy-to-use safety monitors that can be employed in various healthcare settings, including care homes, pharmacies, and general practice clinics. Its product line includes devices designed for peritoneal dialysis and urinary catheter systems, as well as monitoring tools for assessing bacterial infections at wound sites. By integrating these devices with existing medical equipment, MicroBioSensor aims to enhance patient care through timely interventions at affordable costs.

Elucid mHealth

Series A in 2017
Elucid mHealth Limited is a medication technology company based in Manchester, United Kingdom, focused on enhancing clinical trial efficiencies through innovative adherence monitoring tools. Incorporated in 2013, the company developed Pill Connect, a sophisticated pill bottle that facilitates real-time remote monitoring of medication adherence. This product allows trial organizers to access vital data on patient dosing, including missed doses, new doses, and overall engagement metrics. By providing a feedback system that connects individual user doses to provider monitoring systems, Elucid mHealth aims to improve the accuracy and efficiency of clinical trials while addressing non-adherence issues.

Proveca

Venture Round in 2017
Proveca Ltd., a pharmaceutical company, identifies, researches, and licenses off-patent medicines with a focus on the pediatric market. The company’s product portfolio focuses on neurology, cardiology, immunology, analgesia, and pain management. It develops medicines for the treatment of sialorrhoea (chronic pathological drooling) and epilepsy; heart failure, haemodynamic insufficiency, and transplant rejection; and acute pain as well as for children with chronic illnesses. The company was founded in 2010 and is based in Daresbury, United Kingdom.

AMR Centre

Venture Round in 2017
AMR Centre Limited is focused on addressing the challenge of antimicrobial resistance through the development of new antibiotics. Established in 2016 and located in Macclesfield, United Kingdom, the company offers development services to organizations globally, partnering with them to expedite the creation of innovative antibiotic solutions. In return for these services, AMR Centre receives a commercial share from the newly developed products. Through its efforts, the company aims to contribute significantly to the fight against drug-resistant infections, improving healthcare outcomes worldwide.

Apex Molecular

Venture Round in 2016
Apex Molecular Ltd provides specialist chemistry services to pharmaceutical, biotechnology (life sciences), and applied chemistry sectors. The company offers laboratory-scale chemistry development services, including high potency synthesis, custom/contract synthesis, and development and scale-up. Its customers include drug discovery, biotechnology, and agritech companies. The company was formerly known as YProTech Ltd. and changed its name to Apex Molecular Ltd in 2019. Apex Molecular Ltd was incorporated in 2008 and is based in Alderley Edge, United Kingdom.

SwabTech

Seed Round in 2016
SwabTech Ltd is a UK-based medical device company that originated from the National Health Service (NHS) to create an automated swab washing device aimed at enhancing intra-operative cell salvage in surgical settings. The company is focused on developing a patented Surgical Swab Washer that automates the extraction of blood from surgical swabs, a task traditionally performed manually. This device allows for the recovery and reuse of blood during high blood loss surgeries, facilitating autologous transfusions directly in the operating theatre. By enabling the timely retrieval of blood for processing and transfusion back to patients, SwabTech's innovation aims to improve clinical outcomes while also offering a cost-effective solution for hospitals.

Blueberry Therapeutics

Venture Round in 2016
Blueberry Therapeutics Ltd. specializes in the development of therapies for diseases characterized by infection and inflammation, with a particular focus on dermatological disorders. Founded in 2011 and based in Alderley Edge, United Kingdom, the company utilizes a nano polymer drug delivery platform to enhance the delivery of small molecules and biologics directly into cells and tissues. Its research and development efforts are aimed at creating effective treatments for conditions such as inflammatory bowel disease, atopic dermatitis, acne, and wound healing. By concentrating on well-validated drug targets and ensuring low toxicity levels in candidate molecules, Blueberry Therapeutics aims to address significant challenges in drug development and improve patient outcomes.

Biorelate

Seed Round in 2016
Biorelate Ltd. is a biomedical research services company based in Oldham, United Kingdom, founded in 2014. The company focuses on the research and development of biomarkers for diagnosing prostate cancer, target validation, and drug development. Biorelate has developed a database platform that curates biomedical knowledge to support innovations in biotechnological research. Its platform is designed to automatically curate valuable biomedical data from various text sources, ingest information from multiple origins, and identify causal interactions between genes, chemicals, drugs, cells, and phenotypes. This functionality enhances the capabilities of scientists engaged in drug discovery and cancer diagnosis, facilitating their research efforts.

Kanichi Research Services

Venture Round in 2016
Kanichi Research Services are developing novel non-invasive diagnostic systems that measure analytes in exhaled breath for the rapid detection and diagnosis of a range of diseases. The lead product is a low-cost, disposable, point of care test for the detection and diagnosis of Helicobacter Pylori (H. pylori), a bacterial infection in the gut which can lead to stomach ulcers and stomach cancer.

Arlabion

Seed Round in 2016
Arlabion Ltd is an agri-tech company based in Huddersfield, United Kingdom, focused on the development of innovative agrochemicals aimed at sustainable crop management. Established in 2014, the company specializes in a novel seed treatment designed to protect crops from fungal infections. This technology enhances the plant's immune system response, improves seed germination, and promotes root system development, thereby reducing the risk of fungal diseases. Arlabion leverages established organic chemistry techniques, typically used in human and animal healthcare, to create less toxic and environmentally damaging solutions for agriculture. The company targets a rapidly growing market for effective and sustainable crop protection methods, addressing the increasing need for safer agricultural practices.

Michelson Diagnostics

Series A in 2014
Michelson Diagnostics is the developer and manufacturer of products based on Multi-Beam Optical Coherence Tomography (OCT), the uniquely powerful, innovative optical imaging technology that is capable of imaging living tissue microstructure at < 10 µm resolution,in real time, to depths of 1 mm or more.

4energy

Corporate Round in 2013
Located in Nottingham, 4energy produces cooling solutions that deliver up to 50% energy savings over traditional cooling products across the data centre and telecoms industries.

Lumora

Venture Round in 2013
Lumora Ltd, a Cambridgeshire Business Park, UK-based molecular diagnostics company. The company intends to use the funds to accelerate its entry into the clinical molecular diagnostic market. Based on its proprietary BART Technology platform, Lumora is developing programs focusing on: - an integrated testing station for gastrointestinal (GI) infections, and - an HIV viral load monitoring system to support drug therapy in the developing world.

activ8 Intelligence

Venture Round in 2013
Activ8 Intelligence Limited specializes in human resources reporting, analytics, and predictive solutions. The company offers a range of services, including HR reporting tools that feature key performance indicators, dashboards, and analytical reports. Its analytic solutions encompass user-friendly tools, such as trend analyzers and data interpretation services, which facilitate understanding and accessibility of results. Additionally, Activ8 provides predictive workforce planning tools that assist organizations in making informed decisions regarding resourcing, recruitment, and talent management. The company also offers human capital consultancy services, including metrics design and data analysis. Founded in 2005 and originally known as active8 Human Resources Limited, it rebranded in March 2007 and is currently based in Farnsfield, United Kingdom.

Haemostatix

Venture Round in 2012
Haemostatix Ltd. is a biotechnology company based in Nottingham, United Kingdom, founded in 2003 as a spin-out from the University of Leicester. The company specializes in a peptide-based platform technology designed to develop innovative products for managing surgical bleeding, with potential applications in tissue repair and regenerative medicine. Its flagship product, PeproStat, is a topical coagulant that can be applied directly to wounds during surgery to effectively control bleeding. The technology is based on a specific peptide sequence that binds to fibrinogen, a crucial protein in clot formation, and can be adapted to various solid supports or soluble carriers. This platform underpins a promising pipeline of first-in-class products aimed at treating different forms of bleeding, including those associated with surgery, trauma, and leukaemia. As of 2016, Haemostatix operates as a subsidiary of Ergomed plc.

Biofortuna

Venture Round in 2012
Biofortuna Limited is a molecular diagnostics company based in the United Kingdom, founded in 2008. It specializes in the development and manufacture of freeze-dried HLA molecular diagnostic kits, including the SSPGo system for HLA genotyping and the Verdict software for analyzing test results. The company's products serve various applications such as companion diagnostics, clinical testing, bio-defense, and veterinary needs. In addition to its diagnostic kits, Biofortuna offers contract development and manufacturing services, including the production of specially formulated cryo-preservatives and custom assay development for clients in the healthcare sector. The company also focuses on creating innovative solutions for the transplantation and hematology markets, developing products for antibody screening, genotyping, and transplant monitoring. Biofortuna distributes its products globally through a network of distributors.

Echo Ltd.

Venture Round in 2012
echo provides an extensive and bespoke range of IT and logistical support services through an outsourced partnership model. The service focused, flexible solutions enhance, expand and complement an existing service portfolio, improving cost efficiency while maintaining the highest quality service levels.

Comply Serve

Venture Round in 2012
Comply Serve Limited is a software company based in Solihull, United Kingdom, specializing in assurance and compliance solutions for highly regulated industries, including rail, aviation, energy, and infrastructure. Founded in 2005, the company developed ComplyPro, a cloud-based platform designed for large-scale infrastructure projects. This platform facilitates compliance monitoring throughout the project lifecycle, ensuring that design, build, and delivery processes adhere to agreed specifications. ComplyPro promotes collaborative working between clients and their supply chains, enhancing governance over assurance processes. By enabling engineering and delivery teams to manage compliance effectively, the software helps project sponsors make informed decisions, ultimately reducing project failure risks and improving overall outcomes. As of November 2016, Comply Serve operates as a subsidiary of Bentley Systems, Incorporated.

Michelson Diagnostics

Venture Round in 2012
Michelson Diagnostics is the developer and manufacturer of products based on Multi-Beam Optical Coherence Tomography (OCT), the uniquely powerful, innovative optical imaging technology that is capable of imaging living tissue microstructure at < 10 µm resolution,in real time, to depths of 1 mm or more.

BioFilm

Venture Round in 2012
BioFilm Limited specializes in designing, developing, and manufacturing thin dissolvable films for various applications, including nutritional supplements, cosmetics, dental products, and medical devices in Europe. The company's product range features oral care films like teeth whitening strips and mouth ulcer patches, as well as food supplement films containing potassium iodide, caffeine, and melatonin. Additionally, BioFilm produces skin lightening films, simethicone strips, wound care films, and various pharmaceutical films, including breath freshener and anti-snoring strips. The company also functions as a private label developer, creating customized film products for the pharmaceutical, consumer goods, and retail industries. Founded in 2003 and based in Glasgow, United Kingdom, BioFilm Limited has established a state-of-the-art manufacturing facility and secured supply agreements with several notable customers. Formerly known as Biofilm Manufacturing Limited, the company changed its name in July 2005 and was previously a subsidiary of Devro plc.

Biofortuna

Venture Round in 2012
Biofortuna Limited is a molecular diagnostics company based in the United Kingdom, founded in 2008. It specializes in the development and manufacture of freeze-dried HLA molecular diagnostic kits, including the SSPGo system for HLA genotyping and the Verdict software for analyzing test results. The company's products serve various applications such as companion diagnostics, clinical testing, bio-defense, and veterinary needs. In addition to its diagnostic kits, Biofortuna offers contract development and manufacturing services, including the production of specially formulated cryo-preservatives and custom assay development for clients in the healthcare sector. The company also focuses on creating innovative solutions for the transplantation and hematology markets, developing products for antibody screening, genotyping, and transplant monitoring. Biofortuna distributes its products globally through a network of distributors.

Stage Coach

Acquisition in 2012
Stagecoach is a network of performing arts schools that teaches children and young people to sing, dance and act in a fun, educational, and stimulating environment

Oracle Care Limited

Venture Round in 2011
Oracle Care Limited specializes in providing residential care and educational services for young people aged ten to eighteen with complex needs. Established in 2005 and based in Silsoe, United Kingdom, the company operates primarily in Staffordshire and Bedfordshire. Its offerings include therapeutic residential childcare, curriculum-based education, and extended support services aimed at fostering a safe environment and positive relationships that enhance self-esteem. Additionally, Oracle Care provides consultancy services to local authorities, assisting with case management challenges and training for individualized assessment and intervention programs. The organization is committed to delivering a holistic approach to care and education, helping young individuals build a better future.

Hangar Seven

Venture Round in 2011
Hangar Seven Limited is a creative production business that offers marketing services to retailers and consumer brands globally. Established in 2007 and headquartered in Macclesfield, United Kingdom, with additional facilities in London, South Manchester, Leeds, and Portugal, the company provides a comprehensive range of services including asset management, creative production, digital marketing, packaging, photography, and retail marketing. Hangar Seven specializes in content strategy, creation, management, and distribution, effectively engaging consumers through various channels such as point of sale, social media, and digital advertising. The company operates large studios for photography and produces a variety of marketing materials, including flyers and catalogues, for distribution across over 87 countries. As of 2017, Hangar Seven operates as a subsidiary of The Hut.com Ltd.

5Degrees

Seed Round in 2011
5Degrees develops mobile and web-based CRM tools for startups and small businesses to grow sales. Its product portfolio includes 5Degrees CRM, an iPhone CRM App; Networker, a business card scanning app; and 5Degrees CRM Web. 5Degrees’s products enable users to import contacts from address books or Google contacts; put people into circles to easily manage overlapping networks; sync contacts with iPhones; use quick notes systems to jot notes; use templated emails and schedule them to be sent in the future; schedule to-do’s or tasks to keep in touch with contacts; receive alerts about the tasks for the day; view to-do lists; and call and email contacts. Its special features include LinkedIn integration, Box.com integration, offline facilities, multi-device synchronization, iPhone interfaces, and more. 5Degrees was founded in June 2011 and is based in Chicago, Illinois.

Haemostatix

Series C in 2011
Haemostatix Ltd. is a biotechnology company based in Nottingham, United Kingdom, founded in 2003 as a spin-out from the University of Leicester. The company specializes in a peptide-based platform technology designed to develop innovative products for managing surgical bleeding, with potential applications in tissue repair and regenerative medicine. Its flagship product, PeproStat, is a topical coagulant that can be applied directly to wounds during surgery to effectively control bleeding. The technology is based on a specific peptide sequence that binds to fibrinogen, a crucial protein in clot formation, and can be adapted to various solid supports or soluble carriers. This platform underpins a promising pipeline of first-in-class products aimed at treating different forms of bleeding, including those associated with surgery, trauma, and leukaemia. As of 2016, Haemostatix operates as a subsidiary of Ergomed plc.

KickSport

Venture Round in 2011
Kicksport.com is a martial arts equipment specialist, providing equipment and uniforms for Judo, Karate, and Taekwondo. KickSport's ethos is to provide quality clothing and exceptional customer service to all. KickSport's values include energy, dedication, leadership, evolution, aspiration, community, fashion, and quality.

Lumora

Series B in 2011
Lumora Ltd, a Cambridgeshire Business Park, UK-based molecular diagnostics company. The company intends to use the funds to accelerate its entry into the clinical molecular diagnostic market. Based on its proprietary BART Technology platform, Lumora is developing programs focusing on: - an integrated testing station for gastrointestinal (GI) infections, and - an HIV viral load monitoring system to support drug therapy in the developing world.

Intelligent Orthopaedics

Venture Round in 2011
Intelligent Orthopaedics designs, develops, and manufactures orthopedic trauma devices for treating and reducing fractures of the tibia. It offers STORM (The Staffordshire Orthopaedic Reduction Machine), a re-usable surgical device for the reduction of fractures throughout the tibia. The company also provides IOS, a single use fixator to treat unstable tibial shaft fractures. Intelligent Orthopaedics was incorporated in 2002 and is based in Newcastle-under-Lyme, United Kingdom. As of September 05, 2016, Intelligent Orthopaedics is in liquidation.

Haemostatix

Venture Round in 2010
Haemostatix Ltd. is a biotechnology company based in Nottingham, United Kingdom, founded in 2003 as a spin-out from the University of Leicester. The company specializes in a peptide-based platform technology designed to develop innovative products for managing surgical bleeding, with potential applications in tissue repair and regenerative medicine. Its flagship product, PeproStat, is a topical coagulant that can be applied directly to wounds during surgery to effectively control bleeding. The technology is based on a specific peptide sequence that binds to fibrinogen, a crucial protein in clot formation, and can be adapted to various solid supports or soluble carriers. This platform underpins a promising pipeline of first-in-class products aimed at treating different forms of bleeding, including those associated with surgery, trauma, and leukaemia. As of 2016, Haemostatix operates as a subsidiary of Ergomed plc.

Oxford Cryosystems

Acquisition in 2010
Oxford Cryosystems Ltd is a UK-based manufacturer specializing in scientific cooling instrumentation and related software, with a strong focus on applications in X-ray crystallography and other scientific fields. The company produces a range of products, including the Cryostream Cooler, which is utilized for low-temperature X-ray diffraction, as well as open-flow coolers for single crystal and closed chamber cooling. Additionally, it offers Gifford McMahon cryocoolers, Coolstar coldheads, and Cryodrive helium compressors, catering to a variety of applications in pharmaceuticals, telecommunications, green energy, and astronomy. Established in 1964 and initially operating as N.H. Eastwood & Son Limited, Oxford Cryosystems has evolved from its origins in an Oxford University laboratory in the 1980s into a leading commercial entity. With a global customer base comprising universities, high-tech manufacturers, drug companies, and research institutes, the company exports over 80% of its products and sources around 90% of its supplies from British-based suppliers.

nanoTherics

Venture Round in 2010
nanoTherics Limited is a company based in Stoke-on-Trent, United Kingdom, that specializes in developing scientific devices and products for research laboratories in the biotechnology, life science, and pharmaceutical sectors. Founded in 2007, nanoTherics offers advanced technologies such as the magneTherm for magnetic fluid and nanoparticle hyperthermia testing, and live cell alternating magnetic field exposure systems for in vitro imaging. Their product line includes magnetic nanoparticles and lipid-based transfection reagents designed for applications in drug screening, gene therapy, and bioseparation. The company’s gene transfection technology has demonstrated significant performance improvements over existing non-viral techniques, allowing for high transfection rates while preserving cell viability, thus positioning it as a competitive alternative in the market. Through its innovative solutions, nanoTherics aims to support the development of therapies for genetic disorders and diseases such as cancer and Parkinson's. The company also provides its products for sale online.

Yospace Technologies

Venture Round in 2010
Yospace is a mobile applications innovator and platform provider allowing digital publishers, mobile applications developers, and mobile operators to rapidly and affordably deliver mobile video services. The technology enables intelligent streaming thus promoting ad insertion and ad replacement enabling the content owner to monetise their content effectively. It specializes in workflow and delivery for multi-screen non-linear, linear, and live streaming. The company offers yospaceCDS, a mobile and Web-based video delivers platform that provides a basis for publishers, broadcasters, video ad networks, and applications developers to enable live and on-demand video services with in-stream ad insertion. It also offers a range of broadcast head-end solutions to enable the stream conditioning and ad avail detection required for dynamic ad insertion in live streaming, including automation system integration, placement opportunity information service, scheduling integration, and blackout management. The company was founded in 1999 and is based in Staines-upon-Thames, United Kingdom. Yospace Technologies Ltd. is a former subsidiary of Bauer Consumer Media Ltd.

Crystallon

Venture Round in 2010
Crystallon Limited is the holding company for Oxford Cryosystems Limited which produces a world leading portfolio of low temperature devices in the field of x-ray crystallography.

Silver Lining Solutions

Venture Round in 2010
Silver Lining Solutions Limited specializes in employee performance optimization software tailored for international call centers. The company’s innovative solutions enhance employee engagement and performance by identifying individual skills and knowledge, ensuring that customer inquiries are directed to the most qualified personnel. Their software suite includes tools for diagnosing performance issues, scheduling assessments, importing performance data, and generating customized development plans to address skill gaps. Additionally, it facilitates various training methods such as e-learning, coaching, and team meetings. Founded in 1999 and headquartered in Solihull, United Kingdom, Silver Lining Solutions also maintains offices in Asia Pacific and the United States. The company has established strategic partnerships with notable organizations in the telecommunications sector, enhancing its ability to deliver impactful solutions. As of February 2017, Silver Lining Solutions operates as a subsidiary of Genesys Telecommunications Laboratories, Inc.
Renewable Technical Services Limited is a provider of installation, repair and maintenance services to the wind energy sector. The company supports major OEMs under preferred supplier / framework agreements, as well as working for the major power companies and wind-farm operators under long-term arrangements. With over 20 years of experience in installation and maintenance of met masts and wind turbines, the RTS team is available 24 hours a day, 7 days a week to support the wind energy industry. Having provided services to over 268 wind farms in the UK, it has worked on over 5,000 wind turbines. Our reach extends further still, with RTS engineers having worked on contracts in New Zealand, the Dominican Republic, Libya, South Africa and throughout Europe.

Biofortuna

Venture Round in 2010
Biofortuna Limited is a molecular diagnostics company based in the United Kingdom, founded in 2008. It specializes in the development and manufacture of freeze-dried HLA molecular diagnostic kits, including the SSPGo system for HLA genotyping and the Verdict software for analyzing test results. The company's products serve various applications such as companion diagnostics, clinical testing, bio-defense, and veterinary needs. In addition to its diagnostic kits, Biofortuna offers contract development and manufacturing services, including the production of specially formulated cryo-preservatives and custom assay development for clients in the healthcare sector. The company also focuses on creating innovative solutions for the transplantation and hematology markets, developing products for antibody screening, genotyping, and transplant monitoring. Biofortuna distributes its products globally through a network of distributors.

Oxford Biotherapeutics

Venture Round in 2010
Oxford BioTherapeutics (OBT) is focused on the development of targeted medicines in the field of cancer. The company has signed strategic partnerships with the leading antibody companies Medarex, Biosite and Amgen to build a broad pipeline of novel antibody therapeutics using its unique OGAP® (Oxford Genome Anatomy Project) platform. OGAP® is one of the world’s largest proprietary human protein databases which contains and combines proteomic and genomic data with related clinical information. OBT also intends to develop companion diagnostics for selected antibody programmes. The company expects to improve disease management and treatment outcomes by integrating diagnostics into product development and commercialisation activities.

Zinwave

Funding Round in 2010
Zinwave specializes in the development of a Wideband Active Distributed Antenna System (DAS) that enhances indoor wireless connectivity. Founded through a quest for improved wireless solutions rather than a conventional business opportunity, the company emerged from the research of leading academic minds who sought better methods for transmitting radio frequencies indoors. Since the introduction of its first commercial product in 2008, Zinwave has successfully installed its distributed antenna systems across various sectors, including commercial real estate, healthcare, hospitality, education, and public venues. The company's patented ultra-wideband radio frequency fiber solutions are designed to optimize connectivity for mobile network operators, integrators, and end users. Zinwave is committed to not only meeting but exceeding customer needs through innovative and effective solutions.

Intellitect

Venture Round in 2010
Intellitect specializes in developing advanced water quality monitoring systems that enhance the ability of water companies to ensure the safety and quality of their products as they move through distribution networks. Their Insight system is designed to monitor drinking water, wastewater, and natural water resources by utilizing multiparameter instruments that gather and analyze various water quality metrics. This system provides real-time alerts and detailed information about potential quality issues, allowing users to quickly identify problems and respond effectively. By transmitting data to individual sensors and devices, Intellitect enables clients to access comprehensive statistics that support informed decision-making and help maintain high standards of water quality throughout the distribution process.

Intamac

Venture Round in 2009
Intamac Systems Ltd. operates a cloud-based platform that facilitates connectivity for the Internet of Things (IoT), primarily targeting original equipment manufacturers (OEMs) and product vendors. Established in 2000 and headquartered in Northampton, United Kingdom, with additional offices in Cambridge and Trivandrum, the company enables businesses to enhance their service offerings and customer engagement for connected home solutions. Intamac provides an open platform that supports two-way monitoring and control of various appliances and devices, allowing users to manage their home and business environments remotely through mobile devices or the Internet. The platform is equipped with a messaging service that delivers alerts for various incidents, including power failures, floods, fires, and security breaches. Additionally, Intamac offers a full access license program that grants companies control over the IoT software, allowing them to develop custom solutions in a low-risk manner.

Probe Scientific

Series A in 2009
Probe Scientific is developing innovative products to solve clinical problems and improve healthcare. The company has a substantial product pipeline based on its proprietary technologies and is seeking to commercialise this range to simultaneously benefit clinicians and the community in general. Probe Scientific Ltd is a private company, founded in 1998 and is based in the West Midlands, UK. Probe Scientific has grown steadily since its origins as a research organisation and has recently recruited experienced senior executives with a commercial focus.

Accutronics

Venture Round in 2009
Accutronics Ltd designs, develops, and manufactures rechargeable batteries for portable and handheld electronic devices. The company offers accupro, custom designed battery packs and chargers for professional applications. It serves military, defense and security, medical and healthcare, industrial electronics, back-up systems, and portable electronic equipment markets. Accutronics Ltd engages in the distribution of range of Inspired Energy standard smart batteries, chargers and accessories The company was incorporated in 2009 and is based in Newcastle under Lyme, United Kingdom. As of January 13, 2016, Accutronics Ltd operates as a subsidiary of Ultralife Batteries (UK) Ltd.

Systems Integration (Trading) Limited

Private Equity Round in 2009
Systems Integration (Trading) Limited is a provider of software and hardware solutions specifically designed for the food processing industry. The company offers a range of products, including Sistem 7 SHOP FLOOR DATA CAPTURE, which streamlines the manual capture and transfer of information; Sistem 7 SALES ORDER PROCESSING, featuring an Explorer interface for enhanced order management; and Sistem 7 BONING HALL, which facilitates the issuance of quarters to boning hall stock at the start of processing. Additionally, it provides Sistem 7 OUTER CASE MARKER for weighing and labeling products rapidly, Sistem 7 DESPATCH & TRACKER for monitoring order dispatch status, and Sistem 7 STOCK & TRACKER for managing stock visibility and shelf life. Systems Integration (Trading) Limited also offers help desk support, remote diagnostics, software upgrades, and operational consultancy services. Founded in 1994, the company is headquartered in Lichfield, United Kingdom.

Systems Integration

Venture Round in 2009
Systems Integration specializes in providing advanced hardware and software solutions tailored for the meat processing industry. The company combines extensive field experience with cutting-edge technology to enhance operational efficiency within organizations. Its offerings include enterprise resource planning (ERP) and manufacturing execution system (MES) software focused on regulatory compliance, margin improvement, and quality control. By delivering sector-specific software and tools for planning, quality assurance, and traceability, Systems Integration enables clients to streamline their supply chains, reduce waste, and ultimately improve profitability.

Monica Healthcare

Venture Round in 2009
Based in the United Kingdom, Monica Healthcare is developing a series of innovative wearable devices that will use wireless technologies to facilitate globally accessible obstetric services in the home and hospital. The patented technology is based on the acquisition of electro-physiological signals that can be passively detected by electrodes positioned on the maternal abdomen.

Warwick Effect Polymers

Venture Round in 2009
Warwick Effect Polymers Limited manufactures and markets complex polymers using living controlled radical polymerization.

Comply Serve

Venture Round in 2009
Comply Serve Limited is a software company based in Solihull, United Kingdom, specializing in assurance and compliance solutions for highly regulated industries, including rail, aviation, energy, and infrastructure. Founded in 2005, the company developed ComplyPro, a cloud-based platform designed for large-scale infrastructure projects. This platform facilitates compliance monitoring throughout the project lifecycle, ensuring that design, build, and delivery processes adhere to agreed specifications. ComplyPro promotes collaborative working between clients and their supply chains, enhancing governance over assurance processes. By enabling engineering and delivery teams to manage compliance effectively, the software helps project sponsors make informed decisions, ultimately reducing project failure risks and improving overall outcomes. As of November 2016, Comply Serve operates as a subsidiary of Bentley Systems, Incorporated.

Comply

Venture Round in 2009
Comply specializes in providing off-the-shelf scientific and process data management software tailored for the Life Sciences sector. The company also offers professional consulting services designed to help Life Science companies meet the specific demands of their industry. Additionally, Comply delivers quality assurance services for web, cloud, and mobile applications, particularly in the realm of digital health products. Their expertise includes the validation of computerized systems such as enterprise IT and laboratory systems, as well as IT infrastructure validation, which encompasses information security and disaster recovery plans. Through these services, Comply supports organizations in maintaining compliance and enhancing operational efficiency.

Oxford Biotherapeutics

Venture Round in 2009
Oxford BioTherapeutics (OBT) is focused on the development of targeted medicines in the field of cancer. The company has signed strategic partnerships with the leading antibody companies Medarex, Biosite and Amgen to build a broad pipeline of novel antibody therapeutics using its unique OGAP® (Oxford Genome Anatomy Project) platform. OGAP® is one of the world’s largest proprietary human protein databases which contains and combines proteomic and genomic data with related clinical information. OBT also intends to develop companion diagnostics for selected antibody programmes. The company expects to improve disease management and treatment outcomes by integrating diagnostics into product development and commercialisation activities.

Key Technologies

Seed Round in 2008
Key Technologies Ltd. is a specialist engineering company based in Cradley Heath, United Kingdom, that provides engineering solutions primarily for Defense and Homeland Security. Founded in 2003, the company manufactures and supplies a range of products including specialist ammunition, 12 gauge rounds, explosive ordnance disposal (EOD) equipment, and public order solutions. These products are distributed globally through an extensive network. In addition to manufacturing, Key Technologies engages in design, electronic manufacturing, and through-life system engineering services, offering comprehensive support throughout the lifecycle of its products.

4energy Ltd.

Venture Round in 2008
4energy Ltd. develops energy cooling systems and platforms for telecommunications and equipment rooms.

4energy

Venture Round in 2008
Located in Nottingham, 4energy produces cooling solutions that deliver up to 50% energy savings over traditional cooling products across the data centre and telecoms industries.

Sight and Sound Limited

Acquisition in 2008
Sight and Sound Technology Limited is a UK-based company that specializes in distributing hardware and software solutions for individuals who are blind, visually impaired, or have learning and reading difficulties. Founded in 1982 and headquartered in Northampton, the company offers a wide range of products, including braille displays, electronic video magnifiers, screen readers, and talking barcode scanners. In addition to these products, Sight and Sound provides services such as audit and assessment, solution design, training, and ongoing customer support. The company caters to a diverse clientele, including individuals, charities, government entities, educational institutions, and corporations, and also sells its products online. With a focus on assistive technologies, Sight and Sound aims to empower users by enhancing their day-to-day activities and helping them realize their potential.

Oxford Biotherapeutics

Venture Round in 2008
Oxford BioTherapeutics (OBT) is focused on the development of targeted medicines in the field of cancer. The company has signed strategic partnerships with the leading antibody companies Medarex, Biosite and Amgen to build a broad pipeline of novel antibody therapeutics using its unique OGAP® (Oxford Genome Anatomy Project) platform. OGAP® is one of the world’s largest proprietary human protein databases which contains and combines proteomic and genomic data with related clinical information. OBT also intends to develop companion diagnostics for selected antibody programmes. The company expects to improve disease management and treatment outcomes by integrating diagnostics into product development and commercialisation activities.

Silver Lining Solutions

Venture Round in 2008
Silver Lining Solutions Limited specializes in employee performance optimization software tailored for international call centers. The company’s innovative solutions enhance employee engagement and performance by identifying individual skills and knowledge, ensuring that customer inquiries are directed to the most qualified personnel. Their software suite includes tools for diagnosing performance issues, scheduling assessments, importing performance data, and generating customized development plans to address skill gaps. Additionally, it facilitates various training methods such as e-learning, coaching, and team meetings. Founded in 1999 and headquartered in Solihull, United Kingdom, Silver Lining Solutions also maintains offices in Asia Pacific and the United States. The company has established strategic partnerships with notable organizations in the telecommunications sector, enhancing its ability to deliver impactful solutions. As of February 2017, Silver Lining Solutions operates as a subsidiary of Genesys Telecommunications Laboratories, Inc.

Haemostatix

Venture Round in 2008
Haemostatix Ltd. is a biotechnology company based in Nottingham, United Kingdom, founded in 2003 as a spin-out from the University of Leicester. The company specializes in a peptide-based platform technology designed to develop innovative products for managing surgical bleeding, with potential applications in tissue repair and regenerative medicine. Its flagship product, PeproStat, is a topical coagulant that can be applied directly to wounds during surgery to effectively control bleeding. The technology is based on a specific peptide sequence that binds to fibrinogen, a crucial protein in clot formation, and can be adapted to various solid supports or soluble carriers. This platform underpins a promising pipeline of first-in-class products aimed at treating different forms of bleeding, including those associated with surgery, trauma, and leukaemia. As of 2016, Haemostatix operates as a subsidiary of Ergomed plc.

BWB Consulting

Private Equity Round in 2008
BWB Consulting is an integrated engineering and environmental consultancy that delivers multi-disciplinary engineering solutions to the property, development and construction industry. BWB Consulting provides over 70 services, in 15 sectors to an international client base. It offers building and built environment services ranging from designing new buildings to adapting, refurbishing, and maintaining existing building stocks; and from initial feasibility study to planning, detailed design, construction, routine maintenance, decommissioning, and demolition services for public and private sector development projects. Its environment services include advisory, investigative, design, and validation services relating to various aspects of the ground and water environment. The company also provides transport and infrastructure services, which include planning and designing multi-modal transport infrastructure. It serves industrial and manufacturing, education, retail, leisure and hospitality, residential, distribution, energy and carbon, retail, urban regeneration, commercial, health, public, culture and heritage, road and rail, finance and investment, and water environment sectors. The company was founded in 1990 and is based in Nottingham, United Kingdom. As of July 12, 2017, BWB Consulting Limited operates as a subsidiary of Construcciones y Auxiliar de Ferrocarriles, S.A.

activ8 Intelligence

Venture Round in 2008
Activ8 Intelligence Limited specializes in human resources reporting, analytics, and predictive solutions. The company offers a range of services, including HR reporting tools that feature key performance indicators, dashboards, and analytical reports. Its analytic solutions encompass user-friendly tools, such as trend analyzers and data interpretation services, which facilitate understanding and accessibility of results. Additionally, Activ8 provides predictive workforce planning tools that assist organizations in making informed decisions regarding resourcing, recruitment, and talent management. The company also offers human capital consultancy services, including metrics design and data analysis. Founded in 2005 and originally known as active8 Human Resources Limited, it rebranded in March 2007 and is currently based in Farnsfield, United Kingdom.

r2c Online

Seed Round in 2008
r2c Online Limited offers an online platform designed for compliance, quoting, authorization, and invoicing within the European road transport sector. The platform facilitates connections among vehicle manufacturers, dealers, repairers, workshops, fleet operators, and fleet management companies, allowing users to store and manage service, inspection, and compliance records efficiently. Catering primarily to small and medium-sized enterprises as well as larger corporate clients, r2c Online has established itself as a key player in the digital fleet management landscape. Founded in 2003 and headquartered in Sheffield, United Kingdom, r2c Online operates as a subsidiary of FleetCor Technologies, Inc. since April 2019.

Abzena

Venture Round in 2008
Abzena is a provider of services and technologies that facilitate the selection, development, and manufacturing of biopharmaceutical products on a global scale, with operations in North America and Europe. The company specializes in antibody drug conjugates (ADCs), offering proprietary technologies such as ThioBridge and solutions for antibody humanization, protein deimmunization, and immunogenicity assessment. Abzena supports the discovery and development of antibodies through its phage display, Hybridoma sequencing, and developability assessment solutions. Additionally, it provides extensive bioassays and bioanalytics to characterize drug-conjugates and assess candidate selection. The company also engages in the contract development and manufacturing of various biopharmaceuticals, including monoclonal antibodies, recombinant proteins, and gene therapy products. With a diverse client base that includes major biopharmaceutical companies and academic institutions, Abzena aims to enhance therapeutic innovation through its comprehensive suite of services and technologies. Established in 2014, the company is headquartered in Cambridge, United Kingdom.

SolarTech Ltd.

Venture Round in 2008
SolarTech Ltd., is the designer and installers of renewable energy systems.

Eden Luxury Group

Venture Round in 2008
Eden Luxury Group is a Chester-based travel brand specializing in high-end holidays through its Seasons in Style and Eden Collection offerings. The company operates as a tour and travel provider, delivering premium travel services across Europe, Asia, and Australia. Clients can enjoy a range of luxurious travel options, including private jets, yachts, and luxury cars, ensuring a convenient and upscale travel experience. Eden Luxury Group is committed to offering its clientele memorable vacations tailored to their preferences.

Atlantic Link Limited

Venture Round in 2008
Atlantic Link Limited develops rapid e-learning training products which enable users to design and deliver professional on-line training to thousands of employees which would, in the past, have taken months to create at great cost. It offers Content Point, a remote authoring system that enables the development of e-learning courses; Capture Point, a capture tool for the automatic creation of online software training courses; and Knowledge point, a collaboration server and learning management system that provides course launch and tracking, results storage, student import, and user and author grouping functions. The company also specializes in project management, instructional design, branding and design, technical, and account management areas, as well as provides eLearning support and hosted solutions. It serves corporate clients, as well as government and higher education markets through a network of resellers globally. Atlantic Link Limited was founded in 2002 and is based in Nottingham, United Kingdom with an additional office in Atlanta, Georgia.

L3 Technology

Venture Round in 2008
L3 Technology develops a point of care testing system for reading blood analytes from various samples. It offers a lipid profile testing system for measuring a multi-fraction lipid profile from a finger stick sample of blood, serum, or plasma. The company was incorporated in 2001 and is based in Coventry, United Kingdom. As of December 16, 2016, L3 Technology was acquired by Jupiter Diagnostics.

CellAura

Venture Round in 2008
CellAura Technologies, Ltd. specializes in providing innovative screening products for the drug discovery industry. Originating as a spin-out from the University of Nottingham, the company leverages expertise in synthetic chemistry and molecular pharmacology to develop high-quality fluorescent ligands targeting various receptors, including adenosine, beta-adrenergic, dopamine, histamine, and muscarinic receptors. In addition to its product offerings, CellAura provides a contract fluorescent ligand development and validation service, allowing for the synthesis of custom products accompanied by comprehensive pharmacological characterization. Based in Nottingham, United Kingdom, CellAura aims to enhance molecular pharmacology and imaging capabilities at the single-cell level.

Synchro

Venture Round in 2007
Synchro Software Ltd. specializes in developing advanced digital construction software aimed at enhancing the management of complex construction projects. Founded in 2001 and headquartered in Birmingham, United Kingdom, with additional offices in the United States, the company offers a comprehensive suite of tools including a 4D building information modeling platform for visual planning and scheduling. Its flagship product, Synchro 4D, allows users to visualize projects in both 3D and 4D, enabling effective communication of resource properties and facilitating collaborative project management through its Synchro Server. The software is designed to optimize construction plans, ultimately improving safety, reliability, and productivity across various construction sectors, including commercial, civil, and residential projects. Synchro serves a diverse client base, from large corporations to local consultants, both in the UK and internationally. As of June 2018, it operates as a subsidiary of Bentley Systems, Incorporated.

Monica Healthcare

Venture Round in 2007
Based in the United Kingdom, Monica Healthcare is developing a series of innovative wearable devices that will use wireless technologies to facilitate globally accessible obstetric services in the home and hospital. The patented technology is based on the acquisition of electro-physiological signals that can be passively detected by electrodes positioned on the maternal abdomen.

Blackstar Amplification

Private Equity Round in 2007
Blackstar Amplification Limited, a UK-based designer and manufacturer of innovative guitar amplifiers and effects pedals. Blackstar Amplification is based in Northampton, England. The company's four founding directors are all musicians and have over 50 years combined experience in guitar amplification design and production.

R5 Pharmaceuticals Ltd.

Seed Round in 2007
R5 Pharmaceuticals Ltd. engages in the contract development and manufacture of clinical trials materials.

Critical Pharmaceuticals

Series B in 2007
Critical Pharmaceuticals Limited is a biotechnology company based in Nottingham, United Kingdom, that specializes in the development of biological drug products using innovative drug delivery technologies. Founded in 2002 by Professor Steve Howdle, the company focuses on non-invasive nasal delivery and sustained release formulations for proteins, peptides, and small molecules. Its proprietary technologies, CriticalSorb and CriticalMix, facilitate the nasal delivery of biologics and the manufacture of depot products that allow for infrequent injections. The company's product pipeline includes CP024, a nasal growth hormone for growth hormone deficiency; CP046, a nasal treatment for osteoporosis; and CP057, a sustained-release formulation of Bevacizumab for age-related macular degeneration, among others. However, as of July 31, 2017, Critical Pharmaceuticals Limited has entered liquidation.

Oxford Biotherapeutics

Venture Round in 2007
Oxford BioTherapeutics (OBT) is focused on the development of targeted medicines in the field of cancer. The company has signed strategic partnerships with the leading antibody companies Medarex, Biosite and Amgen to build a broad pipeline of novel antibody therapeutics using its unique OGAP® (Oxford Genome Anatomy Project) platform. OGAP® is one of the world’s largest proprietary human protein databases which contains and combines proteomic and genomic data with related clinical information. OBT also intends to develop companion diagnostics for selected antibody programmes. The company expects to improve disease management and treatment outcomes by integrating diagnostics into product development and commercialisation activities.

Zysis

Venture Round in 2007
Zysis Limited is a pharmaceutical company focused on optimizing therapies for central nervous system disorders to enhance the quality of life for affected individuals. The company is in the process of developing two innovative treatments: a once-weekly oral tablet designed for psychotic conditions or as an adjunct for Major Depressive Disorder, and a once-daily formulation aimed at specialty anxiety disorders, including Panic Disorders and Post-Traumatic Stress Disorder. Through its research and development efforts, Zysis is committed to providing effective therapeutic options for medical practitioners, ultimately striving to improve patient outcomes in the field of mental health.

Anaxsys

Venture Round in 2007
Anaxsys Technology Ltd is a medical device company based in Send, United Kingdom, specializing in the development and marketing of respiratory devices. Founded in 2002 and previously known as Asthma Alert Limited, Anaxsys offers products such as respiR8, a continuous respiratory rate counter designed to provide early indications of patient deterioration. The company's focus is on patient monitoring, screening, and diagnostics across various respiratory conditions, including asthma, vital signs, sleep apnea, and lung cancer. Anaxsys aims to enhance patient safety by enabling healthcare professionals to detect respiratory illnesses early, particularly in post-operative, trauma, and emergency care settings.

Michelson Diagnostics

Seed Round in 2007
Michelson Diagnostics is the developer and manufacturer of products based on Multi-Beam Optical Coherence Tomography (OCT), the uniquely powerful, innovative optical imaging technology that is capable of imaging living tissue microstructure at < 10 µm resolution,in real time, to depths of 1 mm or more.

Whelan Refining

Venture Round in 2006
Whelan Refining Ltd recycles waste oil to produce base oil - the base for all industrial and automotive lubricants. It re-refines 50,000 tonnes per annum of used oils to produce a high-quality group I base oil for sale to the lubricant manufacturing industry. Whelan Refining was founded in 2005 and is based in Stoke-on-Trent, UK.

David Holmes BMW

Private Equity Round in 2006
Sytner Group Limited operates as a new and used car dealership company.

Critical Pharmaceuticals

Venture Round in 2005
Critical Pharmaceuticals Limited is a biotechnology company based in Nottingham, United Kingdom, that specializes in the development of biological drug products using innovative drug delivery technologies. Founded in 2002 by Professor Steve Howdle, the company focuses on non-invasive nasal delivery and sustained release formulations for proteins, peptides, and small molecules. Its proprietary technologies, CriticalSorb and CriticalMix, facilitate the nasal delivery of biologics and the manufacture of depot products that allow for infrequent injections. The company's product pipeline includes CP024, a nasal growth hormone for growth hormone deficiency; CP046, a nasal treatment for osteoporosis; and CP057, a sustained-release formulation of Bevacizumab for age-related macular degeneration, among others. However, as of July 31, 2017, Critical Pharmaceuticals Limited has entered liquidation.

Monica Healthcare

Seed Round in 2005
Based in the United Kingdom, Monica Healthcare is developing a series of innovative wearable devices that will use wireless technologies to facilitate globally accessible obstetric services in the home and hospital. The patented technology is based on the acquisition of electro-physiological signals that can be passively detected by electrodes positioned on the maternal abdomen.

Ergomed

Venture Round in 2005
Ergomed plc is a profitable UK-based company, dedicated to the provision of specialized services to the pharmaceutical industry and the development of new drugs. It operates globally in over 40 countries. Ergomed plc has two complementary businesses: - The Services Business – a well-established, clinical research business providing services to the pharmaceutical and biotechnology industry; and - The Co-Development Business – a growing portfolio of partnerships with pharmaceutical and biotech companies, providing its drug development services in exchange for a carried interest in any revenues attributable to the drug asset, including outlicensing milestones as well as sales of the product.

Demon Tweeks

Acquisition in 2004
Demon Tweeks is a retailer specializing in high-performance equipment and accessories for motorsport competitors, car tuners, and motorcycle enthusiasts. The company offers a wide range of motor parts and equipment, catering to the needs of both amateur and professional users in the automotive and motorsport industries. Through its extensive product offerings, Demon Tweeks serves as a key resource for individuals looking to enhance their vehicles' performance and aesthetics.

Cyclops

Venture Round in 2004
Cyclops offers safety camera databases, update services, and related software. Cyclops' coverage now extends across 41 countries and includes over 85,000 sites. Users of Cyclops devices, software and databases know they can rely on Cyclops' solutions to help them arrive safely at their destination, and with their driving record intact. Cyclops delivers tailored solutions for clients operating on all types of software and hardware platforms including personal navigation, connected mobile devices, and OEM satnav solutions. Today, Cyclops' databases and software can be found in leading satellite navigation, mobile, and automotive brands, Cyclops now provides a Live Alert Service for connected PND and mobile navigation users.

Cyclops Electronics

Venture Round in 2004
Cyclops Electronics Ltd. distributes electronic components to original equipment manufacturers worldwide.

De-Pack Ltd.

Venture Round in 2004
De-Pack Ltd. provides de-packaging, recycling, and recovery of aerosols.

Food & Drug Analytical Services

Venture Round in 2004
Food and Drug Analytical Services Ltd. is an independent providers of pharmaceutical quality control testing. FDAS delivers a full contract testing service - incorporating chemistry, microbiology, stability and development capabilities - to some of the UK's largest pharmaceutical companies.

Turbine Efficiency

Venture Round in 2003
Turbine Efficiency, founded in 2000 and headquartered in Lincoln, UK, specializes in after-market services for industrial gas turbines, particularly those under 10MW. The company provides maintenance, repair, and overhaul services for various gas turbines, including the SGT-100, SGT-200, SGT-300, and TA and TB models. Turbine Efficiency also offers light industrial gas turbine equipment solutions, catering to the oil, gas, and power industries. The company has been recognized for its contributions to the sector, winning the Lincolnshire Energy Awards - Exporter of the Year in 2014.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.